Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Glutamine for Radiation-Induced Mucositis in Head and Neck Cancer
NCT00006994Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 2001
- Primary completion
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in oral mucositis (OM) comparing L-glutamine + Radiation with Placebo + Radiation (2 arms). Primary endpoints: Maximum Mucositis Toxic Effects and Worst Reported Mouth Pain. Started Nov 2001; status: terminated.
02
Drugs
glutamine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00006994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006994.